Research Candidates

 
News Articles for Research Candidates top ^
2014/9/25
Bausch + Lomb and Nicox's Glaucoma Candidate VESNEO® (latanoprostene bunod) Meets Primary Endpoint in Phase 3 Studies Canada NewsWire Expect to file in the U.S. in First Half of Q2 2015 Expect to launch in the U.S. in First Half of 2016 Peak U.S. sales ~$500 million+, Peak Global Sales ~$1 billion+ LAVAL, Quebec and SOPHIA ANTIPOLIS, France , Sept.
Sign-up for Bausch + Lomb and Nicox's Glaucoma Candidate VESNEO® (latanoprostene bunod) Meets Primary Endpoint in Phase 3 Studies investment picks
Cornerstone OnDemand (NASDAQ:CSOD), a global leader in cloud-based talent management software solutions, today announced that the company will showcase its latest product innovations created to help organizations provide a positive candidate experience and strong employer brand at the 17 th Annual HR Technology Conference & Expo, being held at Mandalay Bay in Las Vegas on October 7-10.
Sign-up for New Cornerstone Recruiting Enhancements Help Hiring Teams Strengthen Candidate Experience investment picks
Monster (NYSE: MWW) today announced, at the 2014 HR Technology conference in Las Vegas, major enhancements to TalentBin by Monster focused on helping recruiters connect with more of the best candidates than ever before.
Sign-up for Monster Delivers Sophisticated New Social Recruiting Marketing Capabilities, Extends Social Candidate Search to Additional Occupations investment picks
2014/9/15
Rapid, potent, and durable immunity demonstrated with vaccine candidate (VBI-1501A). Pilot scale (10L) production of VBI-1501A expected to meet Phase I trial release criteria.
Sign-up for New Data Supporting VBI's Prophylactic Cytomegalovirus (CMV) Vaccine Candidate (VBI-1501A) Presented at the 54th ICAAC Conference in Washington, D.C. investment picks
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced favorable safety results from the single ascending dose portion of a Phase I study of AVI-7100, the company’s lead candidate for the treatment of influenza virus, in healthy volunteers.
Sign-up for Sarepta Therapeutics Announces Favorable Safety Results from Phase I Clinical Study of Influenza Drug Candidate investment picks
Employers: Tailor Your Sourcing and Interviewing Technology to the Talent You Want to Hire, Advises ManpowerGroup Solutions MILWAUKEE , Oct.
Sign-up for Nine in 10 Candidates Are Still Looking for Personal Approach in the Recruiting Process investment picks
Nexstar Broadcasting Group, Inc. (“Nexstar”) announced today that its three local television stations will provide Iowa voters broadcast coverage of the one hour debate between U.S. Senate candidates, Joni Ernst (GOP) and current U.S. Representative, Bruce Braley (D) on October 16, 2014.
Sign-up for Nexstar Broadcasting to Air Pivotal Iowa Political Debate between U.S. Senate Candidates on October 16 investment picks
2014/11/6
MILWAUKEE , Nov.
Sign-up for Right CareerExpo Offers Employers Virtual, No-Cost Access to Skilled Candidates investment picks
--Candidate Will Target Two Undisclosed Immune Checkpoints --Anti-TIM-3 Antibody Data to be Presented Today at the AACR Conference in Orlando WALTHAM, Mass.
Sign-up for TESARO and AnaptysBio Expand Immuno-Oncology Collaboration to Include Novel Bispecific Antibody Candidate investment picks
Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) “entrectinib” for the company’s lead product candidate, RXDX-101.
Sign-up for Ignyta Receives Approval of Nonproprietary Name Entrectinib for Lead Product Candidate, RXDX-101 investment picks
Vaccine and adjuvant were well-tolerated, consistent with the company's prior studies with saponin-based adjuvants Hemagglutination-inhibiting antibody responses similar to prior Novavax studies of A(H7N9) with another saponin adjuvant Strong neuraminidase inhibiting antibody responses in adjuvanted vaccine groups Matrix-M demonstrated a clear dose response GAITHERSBURG, Md., Sept.
Sign-up for Novavax' H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data investment picks
2014/10/8
CHICAGO , Oct.
Sign-up for CareerBuilder Study Reveals 5 Technology-Related Barriers That Are Killing Your Candidate Experience investment picks
BURLINGTON, Mass., Sept.
Sign-up for Flexion Therapeutics Announces Issuance of U.S. Composition of Matter Patent for Lead Candidate FX006 investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Research Candidates
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Campus  |  Next: Research Capabilities